Similar results were obtained by monitoring endogenous YAP/TAZ target genes by qPCR in mouse E0771 breast cancer cells stably expressing Fascin1 shRNAs (Fig. 1g), which we used to validate shRNAs to be used in vivo (see Fig. 4 below). The gene discussed is YAP1; the disease is breast carcinoma.